292 related articles for article (PubMed ID: 34456925)
1. Hijacking of the Host's Immune Surveillance Radars by
Mariappan V; Vellasamy KM; Barathan M; Girija ASS; Shankar EM; Vadivelu J
Front Immunol; 2021; 12():718719. PubMed ID: 34456925
[No Abstract] [Full Text] [Related]
2. Immune response to Burkholderia pseudomallei.
Panomket P
J Med Assoc Thai; 2011 Nov; 94(11):1410-7. PubMed ID: 22256484
[TBL] [Abstract][Full Text] [Related]
3. Melioidosis: molecular aspects of pathogenesis.
Stone JK; DeShazer D; Brett PJ; Burtnick MN
Expert Rev Anti Infect Ther; 2014 Dec; 12(12):1487-99. PubMed ID: 25312349
[TBL] [Abstract][Full Text] [Related]
4. Immunity to Burkholderia pseudomallei.
Wiersinga WJ; van der Poll T
Curr Opin Infect Dis; 2009 Apr; 22(2):102-8. PubMed ID: 19276877
[TBL] [Abstract][Full Text] [Related]
5. Burkholderia pseudomallei Δ
Khakhum N; Bharaj P; Myers JN; Tapia D; Kilgore PB; Ross BN; Walker DH; Endsley JJ; Torres AG
mSphere; 2019 Jan; 4(1):. PubMed ID: 30602524
[No Abstract] [Full Text] [Related]
6. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease?
Lazar Adler NR; Govan B; Cullinane M; Harper M; Adler B; Boyce JD
FEMS Microbiol Rev; 2009 Nov; 33(6):1079-99. PubMed ID: 19732156
[TBL] [Abstract][Full Text] [Related]
7. Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells.
Dando SJ; Ipe DS; Batzloff M; Sullivan MJ; Crossman DK; Crowley M; Strong E; Kyan S; Leclercq SY; Ekberg JAK; St John J; Beacham IR; Ulett GC
Infect Immun; 2016 Jul; 84(7):1941-1956. PubMed ID: 27091931
[TBL] [Abstract][Full Text] [Related]
8. Distinct Pathogenic Patterns of
Chen YL; Hsu DW; Hsueh PT; Chen JA; Shih PJ; Lee S; Lin HH; Chen YS
Am J Trop Med Hyg; 2019 Oct; 101(4):736-745. PubMed ID: 31392941
[No Abstract] [Full Text] [Related]
9. Variable virulence factors in Burkholderia pseudomallei (melioidosis) associated with human disease.
Sarovich DS; Price EP; Webb JR; Ward LM; Voutsinos MY; Tuanyok A; Mayo M; Kaestli M; Currie BJ
PLoS One; 2014; 9(3):e91682. PubMed ID: 24618705
[TBL] [Abstract][Full Text] [Related]
10. [Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines].
Manzeniuk IN; Galina EA; Dorokhin VV; Kalachev IIa; Borzenkov VN; Svetoch EA
Antibiot Khimioter; 1999; 44(6):21-6. PubMed ID: 10422574
[TBL] [Abstract][Full Text] [Related]
11. Immune Control of
Nithichanon A; Rinchai D; Buddhisa S; Saenmuang P; Kewcharoenwong C; Kessler B; Khaenam P; Chetchotisakd P; Maillere B; Robinson J; Reynolds CJ; Boyton RJ; Altmann DM; Lertmemongkolchai G
Front Immunol; 2018; 9():484. PubMed ID: 29616023
[No Abstract] [Full Text] [Related]
12. Comparison of the early host immune response to two widely diverse virulent strains of Burkholderia pseudomallei that cause acute or chronic infections in BALB/c mice.
Amemiya K; Dankmeyer JL; Fetterer DP; Worsham PL; Welkos SL; Cote CK
Microb Pathog; 2015 Sep; 86():53-63. PubMed ID: 26162294
[TBL] [Abstract][Full Text] [Related]
13. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen.
Stevens MP; Wood MW; Taylor LA; Monaghan P; Hawes P; Jones PW; Wallis TS; Galyov EE
Mol Microbiol; 2002 Nov; 46(3):649-59. PubMed ID: 12410823
[TBL] [Abstract][Full Text] [Related]
14. Virulence of the Melioidosis Pathogen Burkholderia pseudomallei Requires the Oxidoreductase Membrane Protein DsbB.
McMahon RM; Ireland PM; Sarovich DS; Petit G; Jenkins CH; Sarkar-Tyson M; Currie BJ; Martin JL
Infect Immun; 2018 May; 86(5):. PubMed ID: 29440370
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of TNF-α and IFN-γ expression is a common host immune response in a chronically infected mouse model of melioidosis when comparing multiple human strains of Burkholderia pseudomallei.
Amemiya K; Dankmeyer JL; Bearss JJ; Zeng X; Stonier SW; Soffler C; Cote CK; Welkos SL; Fetterer DP; Chance TB; Trevino SR; Worsham PL; Waag DM
BMC Immunol; 2020 Feb; 21(1):5. PubMed ID: 32013893
[TBL] [Abstract][Full Text] [Related]
16. Exploitation of host cells by Burkholderia pseudomallei.
Stevens MP; Galyov EE
Int J Med Microbiol; 2004 Apr; 293(7-8):549-55. PubMed ID: 15149030
[TBL] [Abstract][Full Text] [Related]
17. Interaction between Burkholderia pseudomallei and the host immune response: sleeping with the enemy?
Gan YH
J Infect Dis; 2005 Nov; 192(10):1845-50. PubMed ID: 16235187
[TBL] [Abstract][Full Text] [Related]
18. Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei.
Ulett GC; Ketheesan N; Hirst RG
Infect Immun; 2000 Apr; 68(4):2034-42. PubMed ID: 10722599
[TBL] [Abstract][Full Text] [Related]
19. Novel multi-component vaccine approaches for Burkholderia pseudomallei.
Morici L; Torres AG; Titball RW
Clin Exp Immunol; 2019 May; 196(2):178-188. PubMed ID: 30963550
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of and immunity to melioidosis.
Brett PJ; Woods DE
Acta Trop; 2000 Feb; 74(2-3):201-10. PubMed ID: 10674650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
